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Psoriasis is a chronic inﬂammatory skin disease that affects 0.1%–5% depending on the population. PSORS1 is the
major susceptibility locus, accounting for approximately 33%–50% of the genetic component of psoriasis among
Caucasians. PSORS1 is located within the major histocompatability complex (MHC) locus on 6p21.3. Its position
has been reﬁned to hundreds of kilobase and the region located at  100–200 kb telomeric to human leukocyte
antigen (HLA)-C is a very strong candidate. To determine the MHC psoriasis risk haplotype, we screened the whole
46 kb interval for single-nucleotide polymorphisms (SNP) and identiﬁed 138 SNP. We genotyped 29 SNP throughout
this region in psoriatic nuclear families. We calculated the frequency of haplotypes generated by the 29 SNP using
all genotyped founder individuals and found four common haplotype with frequency 40.10. We then used SNP-
tagger to derive the best six SNP and fed these into Transmit using 148 nuclear families. We found that CTGGAC
haplotype is a single-point score haplotypes telomeric to HLA-C and gives a 1 df, v2 of 50.27 (po0.0001). Most
importantly the six selected SNP accurately tagged the most common haplotype found in this region. Moreover,
using the same program (Transmit) we show that the association with CTGGAC is higher than the one with HLA-
Cw6 (v2¼ 10.53; p¼ 0.0051). Our results give scores as high as the highest single-point scores suggesting that it is
unlikely to be able to discriminate the origin of the association on this analysis on strength of association.
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Psoriasis vulgaris [MIM 177900] is a chronic inflammatory
dermatosis that affects 2%–5% of the Caucasian popula-
tion (Nevitt and Hutchinson, 1996) and 0.1%–0.3% in the
Far East (Simons, 1949) and China (Yui Yip, 1984). It is a
multi-factorial disease involving the interaction of several
genes with environmental factors including streptococcal
infection, stress, smoking, and physical trauma (Swanbeck
et al, 1994; Tagami, 1997). Genomewide scans using a non-
parametric linkage method have revealed linkage to several
regions across the genome. Linkage has been shown on
chromosomes 6p21 (PSORS1 [MIM 177900]) (Leder et al,
1994; Nair et al, 1997; Trembath et al, 1997; Zhang et al,
2002), 1q21 (PSORS4 [MIM 603935] (Capon and Novelli,
1999), 1p (Veal et al, 2001), 19p13 (Lee et al, 2000), and 16q
(Nair et al, 1997). Suggestive linkage includes regions at
chromosomes 3p (Samuelsson et al, 1999), 8q (Trembath
et al, 1997), 15p (Samuelsson et al, 1999), and 20p (Nair
et al, 1997; Trembath et al, 1997). Other studies have also
shown chromosomes 17q (PSORS2 [MIM 603935] (Tom-
fohrde et al, 1994; Nair et al, 1997) and 4q (PSORS3 [MIM
601467]) (Matthews et al, 1996) to be of interest, but these
regions have not been replicated in any genomewide scans
(reviewed by Sagoo et al, 2004a). The latest genomewide
scan performed in the Chinese Han population showed
significant linkage to loci at 6p21 and 4q31 (Zhang et al,
2002). A recent meta-analysis conducted by our group has
shown significant linkage to loci at 6p21.3 and 4q31 in
Caucasian and Han populations, suggesting that genes
within these regions could be involved in the pathogenesis
of psoriasis in both populations (Sagoo et al, 2004b). All the
genomewide studies have revealed highly significant link-
age to a region on the major histocompatability complex
(MHC) at 6p21.3 (PSORS1) and allele sharing between sib-
pairs estimated the contribution to the familial clustering of
disease (l) to 33olo50% (Trembath et al, 1997; The In-
ternational Psoriasis Genetics Consortium, 2003). Human
leukocyte antigen (HLA)-Cw6 was the first allele to show
a strong association with familial psoriasis and is carried
on a Caucasian ancestral haplotype designated EH57.1
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(Schmitt-Egenolf et al, 1996). Subsequently, Nair et al (2000)
refined PSORS1 to a region of approximately 170 kb in-
cluding risk haplotypes RH1 and RH2 telemoric of HLA-C
using a haplotype-based transmission/disequilibrium test
(Spielman et al, 1993) in a Caucasian population (Nair et al,
2000). A case–control study in a Japanese population using
11 polymorphic microsatellite markers distributed over a
1060 kb region surrounding the HLA-C locus located
PSORS1, which covered an interval of 111 kb spanning
89–200 kb, telomeric of HLA-C gene (Oka et al, 1999). In-
terestingly these two studies, although based on different
ethnic groups, showed an overlapping DNA interval of ap-
proximately 110 kb suggesting that PSORS1 is likely to be
located here (Fig 1). Seven genes have been identified
within this candidate DNA interval including POU5F1 or oc-
tamer transcription factor 3 gene (Takeda et al, 1992a, b),
the cell growth regulated gene transcription factor 19
(TCF19) (Ku et al, 1991), a-helix coiled coil rod homologue
(HCR) gene encoding a-helix coiled coil rod homologue
protein (Oka et al, 1999) that was initially identified as Pg8
(Guillaudeux et al, 1998), small proline-rich protein (SPR1)
encoding small proline-rich protein (Oka et al, 1999), S gene
or corneodesmosin (CDSN) (Zhou and Chaplin, 1993),
SEEK1, and STG (Oka et al, 1999). TCF19 is far less pol-
ymorphic than the other genes in the region and showed no
association with psoriasis (Teraoka et al, 2000), suggesting
that the true gene(s) for psoriasis could be telomeric to
TCF19. Therefore, we examined the 46 kb DNA interval lo-
cated 113 kb telomeric to HLA-C for psoriasis mutation(s).
The candidate region contains five genes including HCR,
SPR1, CDSN, SEEK1, and STG (Oka et al, 1999). CDSN and
HCR have been shown to be strongly associated with pso-
riasis and are strong candidates in Caucasian populations
(Tazi-Ahnini et al, 1999; Allen et al, 1999; Jenisch et al, 1999;
Asumalahti et al, 2000, 2002; Orru et al, 2002; Capon et al,
2003). The putative amino acid sequence of HCR shows
that it has a nuclear motif, and HCR has been shown to be
overexpressed in psoriatic lesional epidermis (Asumalahti
et al, 2002), suggesting its possible involvement in the
pathogenesis of the disease. CDSN is involved in cohesion
between keratinocytes (Jonca et al, 2002; Caubet et al,
2004), and in desquamation via a proteolysis mechanism
(Simon et al, 2002). The putative amino acid sequence of
SEEK1 shows no significant homology with known proteins,
and STG shows  50% similarity with prion proteins. SPR1
belongs to a family of small proline-rich proteins, cross-
linked to other corneodesmosomal proteins such as in-
volucrin and loricrin which contribute to the integrity of the
skin barrier (Steinert et al, 1997). Most of the proteins en-
coded by the MHC 46 kb interval seem to have a potentially
important role to play in the physiology of the skin. In order
to identify psoriasis risk haplotypes within the MHC sus-
ceptibility region we screened the whole 46 kb for single-
nucleotide polymorphisms (SNP), constructed haplotypes
using all genotyped founder individuals and used SNPHAP
to get haplotype frequencies. We then selected the best six
SNP and used transmit to determine the susceptibility ha-
plotypes yielding the highest single-point scores.
Results
We established the genetic organization of the region along
46 kb using the MHC sequence available in the public da-
tabase (The MHC Sequencing Consortium, 1999) (Fig 1). We
identified 138 SNP within a 46 kb interval and chose 29
SNP on the basis of their location, frequency and their level
of linkage disequilibrium (LD) with neighboring markers.
The position and nature of each polymorphism is given
in Table I. We identified two SNP in the promoter region of
HCR gene, 22 SNP in the exons (five in HCR exons, four in
SEEK1 exons, nine in CDSN exons, and four in STG exons)
and four SNP in the intronic regions. Of those within the
exons, nine give an amino acid change (four in HCR, three in
SEEK1, and two in CDSN) and nine are in the 30UTR (five in
CDSN and four in STG) (Table I). SNP were also selected on
the basis of their successful genotyping rate. These SNP
Figure 1
Psoriasis candidate region within the MHC region. Adapted from Sagoo et al (2004a). This figure shows the structure and organization of the
major histocompatability complex (MHC) psoriasis candidate region (the MHC sequencing consortium) previously reported are indicated (Oka et al,
1999; Nair et al, 2000).
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had 100% success rate and were genotyped by two differ-
ent methods (see Materials and Methods). LD between all
pairs of markers was estimated by measuring the coeffi-
cient of disequilibrium (D0) (Lewontin, 1984; Excoffier and
Slatkin, 1995). Values of D0 are available online (Table S1).
Results were also displayed using software GOLD (Ab-
ecasis and Cookson, 2000) (Fig 2). There is strong LD along
the whole region. Two domains of strong LD were identified
forming two blocks of markers around CDSN and HCR, re-
spectively (Fig 2). Weak LD was detected between markers
10 and 12 at the borders of HCR and CDSN blocks,
respectively.
We subsequently estimated haplotype frequencies using
all genotyped founder individuals using the SNPHAP pro-
gram to get haplotype frequencies. Haplotypes and fre-
quencies of all those with an estimated frequency 40.05
are given in Table II. To test for association of common ha-
plotypes running over the whole region, we selected a set of
six tagging SNP and tested for transmission distortion of the
haplotypes tagged by these SNP using the program Trans-
mit. The tagging SNP were selected by first estimating ha-
plotypes and their frequencies from the genotype data of
founders only, using the program SNPHAP, and then input-
ting these haplotypes and corresponding frequencies into
the program SNPtagger (Ke and Cardon, 2003) to screen for
the best set of six SNP, which represent the most common
haplotypes. Analysis showed that the SNPtagger haplo-
types are 2, 9, 10, 12, 13, 26, which correspond to C/T in
HCR promoter, A/T in SEEK1 intron 5, A/G in SEEK1 exon 5,
A/G in SEEK1 intron 3, C/A in SEEK1 intron 3, and C/T in
STG 30UTR. Most importantly the six selected SNP accu-
rately tagged the most common haplotype found in this
Figure 2
Pattern of linkage disequilibrium (LD) in the
46 kb psoriasis candidate interval. Coefficients
of disequilibrium (D0) were calculated for each
pairwise combination of candidate region single-
nucleotide polymorphisms. Results were dis-
played graphically using GOLD software (Ab-
ecasis and Cookson, 2000). Colors representing
the degree of LD between markers. Red and
blue colors indicate maximum and minimum LD,
respectively. High LD around a-helix coiled coil
rod homologue (HCR) and corneodesmosin
(CDSN) define two blocks named HCR block
and CDSN block, respectively. Beaks of LD be-
tween the blocks is indicated by blue color.
Table II. Genotypes of the founder individuals have been analyzed using SNPHAP program to get the haplotype frequencies
HCR SEEK1 CDSN STG
Haplotype
frequency
SNP 1 2 3 4 5 6 7 8 9 1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2
0 1 2 3 5 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9
Haplotypes A C T G G T T A T G C G A C T A T T C A A G A G C C A T T 0.166
A C T G G T T A A G C G A C C A T C T A G A G A C T A A C 0.114
A T C C G C T A A G C G C C C A T C T A G G G G C C A T C 0.102
A C C G T C T A A G C A A T T A T T C A A G A G C C A T C 0.098
G T C C G C T G A A C G A C C A T C T G G A G A T C A T C 0.052
A A T G A T G A A G C G A C T G T T C A A G A G C C A T T 0.052
The six SNPtag are indicated in bold within the common haplotype (see also Table S1).
HCR, a-helix coiled coil rod homologue; CDSN, corneodesmosin; SNP, single-nucleotide polymorphism.
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region (see Table II and also Table S2). To estimate the risk
for disease for individuals who carry ATGGAA haplotypes,
175 controls from unrelated individuals and 83 cases were
selected from the dataset used by Transmit. We then carried
out a case–control analysis on this data set. Frequencies
were inferred using SNPHAP software that gave frequencies
of 0.13 and 0.29 in controls and cases, respectively. The w2
test gave an odds ratio for the haplotype of 2.56. To com-
pare the strength of CTGGAC association with psoriasis to
the one with HLA-Cw6 we run Transmit on HLA-Cw6 geno-
typing data. The association with HLA-Cw6 (w2¼10.53;
p¼0.0051) was much lower than the one with CTGGAC
(w2¼50.27; po0.0001) with an odds ratio of 1.93. Details of
frequencies and c2 of each haplotypes are given in Table S2.
Discussion
In this study, we have performed systematic screening for
SNP of 46 kb located 113 kb telomeric to HLA-C locus and
found 138 SNP (one SNP every 333 bp) much higher than
the genome average that was estimated to approximately 1
every 1000 bp (Wang et al, 1998), suggesting that this re-
gion is under strong positive selection. This could be be-
cause of its proximity to class I and class II genes believed
to be under positive pressure (Slade and McCallum, 1992;
Potts and Slev, 1995). We have also defined two blocks and
generally it implies there are more blocks than you see by
eye. If there are two or more blocks, then there must have
been recombination between them, but in this case recom-
bination has not broken the common haplotype, which runs
across the blocks. On the current data, the association is
not with one block or the other. It is entirely with the com-
mon haplotype, and it is interesting that this runs across
blocks. We also tagged the most common haplotypes by
selecting the six best SNP. The results gave the highest
single-point scores, which means we cannot discriminate
the origin of the association on this analysis on strength of
association. In our study, the frequency of the common
haplotype in the general population is 0.16 which is equi-
frequent to that estimated by Elder et al (2001a, b) in Cau-
casian population (frequency¼0.15). Our results show that
in a Caucasian population, the ATGGAA haplotype is more
common than HLA-Cw6 (frequency¼ 0.1) (Tazi-Ahnini et al,
1999) and gave higher risk than HLA-Cw6 in the same
population (2.56 vs 1.93; this study).
However, other genetic and/or environmental factors
must be involved since the prevalence of psoriasis is no
more than 2%–5% in the Caucasian populations. ATGGAA
haplotypes gave the highest w2 value and we believe that
this haplotype gives a good estimation of the risk factor in
individuals who carry it. More recently, family-based studies
using markers along 150 kb around HLA-C suggest that the
strongest association was with two SNP (n.7 and n.9) lo-
cated 4 and 7 kb centromeric to HLA-C, respectively (Veal
et al, 2002). The authors also found strong association to
the region telomeric to HLA-C around the MHC 46 kb in-
terval, the region harboring PSORS1 in both Caucasian and
Japanese psoriatic populations (Oka et al, 1999; Nair et al,
2000; this study). Moreover, the identification of a neutral
chromosome carrying SNP9 in the absence of the CDSN
risk allele supports our hypothesis with regard to the local-
ization of PSORS1 within the 46 kb segment. The possibility
of the presence of two loci within the MHC is also not
excluded. Interestingly, analysis of extended haplotype
CW6ATGGAA comes up significant (data not shown). This
pattern is consistent with a recombination having occurred
between HLA-Cw6 and the candidate region generating a
new risk haplotype. This would argue for the causative fac-
tor being located at the HLA-Cw6 end of things rather than
in the candidate region (but not being HLA-Cw6 itself), or
that there is some sort of interaction between variants lo-
cated at the HLA-Cw6 end and in the candidate region.
The risk haplotype reported here is in agreement with
those reported in previous study (Capon et al, 2003). Table
III shows that Caucasian risk haplotypes at HCR 269 CDSN
1739 and CDSN 1747 between different studies agree ex-
actly. The HCR 269T, CDSN 1739T, and CDSN 1747T ha-
plotype is part of cluster E risk haplotypes (Veal et al, 2002;
Capon et al, 2003). Our results demonstrate that SNPtag
forming haplotype (ATGGAA) is the shortest sequence giv-
ing the highest single-point score (w2¼50.27, 1 df). There-
fore, the ATGGAA haplotype could be used as tool to
evaluate risk for psoriasis. It should be mentioned here that
ATGCAA haplotype could be running beyond the 46 kb.
Therefore, further investigation of the surrounding regions
may become necessary. The genetics of CDSN and HCR
have been intensively investigated showing a strong asso-
ciation between variants within these genes and psoriasis. A
recent study has also shown that SPR1 and SEEK1 are
strongly associated with disease in the Swedish population
(Holm et al, 2003). In addition, we reported the presence of
an insertion of CCCCCCC in exon 5 of the SEEK1 gene.
This will shift the open-reading frame and could affect the
function of Seek1 protein (Table I). SEEK1 gene is the only
gene transcribed in the direction opposite to other genes in
this region, and it encodes a putative transcription factor.
SEEK1 messenger mRNA has been detected in cultured
keratinocytes (Oka et al, 1999) and we have also detected
the expression of Seek1 protein in the epidermis using an-
tisera antibody to Seek1 protein (Rachid Tazi-Ahnini, un-
published). Investigating the effect of CCCCCCC insertion
on the activity of Seek1 protein could be a useful approach
to assess the significance of these observations (Rachid
Tazi-Ahnini et al, unpublished). However, CDSN and HCR
are the strongest candidate genes. CDSN is involved in
cohesion between keratinocytes and in process of desqua-
mation, and we have recently shown that proteolysis of
CDSN is altered in psoriatic lesional skin (Jonca et al, 2002;
Simon et al, 2002; Caubet et al, 2004). The HCRWWCC
allele has been associated with psoriasis in different pop-
ulations and recently Suomela et al (2003) have shown that
Table III. HCR 269, CDSN 1739,
and CDSN 1747 haplotypes on PSORS1
Reference HCR 269T CDSN 1739T CDSN 1747T
Capon et al (2003) þ þ þ
This study þ þ þ
HCR, a-helix coiled coil rod homologue; CDSN, corneodesmosin.
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HCR is downregulated by interferon-g in cultured keratri-
nocytes (Suomela et al, 2003).
In conclusion, we have reported the highest single-point
score within the region telomeric to HLA-C, confirming that
this region is likely to contain the gene truly pathogenic in
psoriasis. ATGGAA haplotype could be used to evaluate risk
of disease in families with a positive family history of pso-
riasis. Functional studies of proteins encoded by these
genes would be an appropriate way to further investigate
the role of this region of the genome in the pathogenesis of
psoriasis.
Subjects and Methods
Psoriasis families Families with chronic plaque psoriasis were
recruited from the South Yorkshire region of the United Kingdom
after obtaining their informed consent, which was approved by the
Sheffield Local Ethics Committee and conformed with the guide-
lines set forth in the Helsinki protocol. The total number of families
entered in this study were 148, comprising of 564 individuals.
There were 72 trios, 49 families with four individuals and 28 missing
a single parent. The rest of the families (n¼ 28) included five, six,
seven, or eight members including families (n¼ 23) missing one
parent. Of the 564 individuals, 235 were affected. Patients with
severe and extensive chronic plaque psoriasis and their family
members were seen and diagnosed by a single consultant der-
matologist, a specialist in the psoriasis clinic (M. J. C.). A cohort of
non-psoriatic unrelated individuals (n¼ 96) who were blood donors
from the Trent Blood transfusion service (Sheffield, UK), were
genotyped for 29 polymorphisms to determine the SNP frequency
and LD between markers.
Heteroduplex analysis using denaturing-high-performance liq-
uid chromatography Oligonucleotides were designed to amplify
products of 400–800 bp in length from the genomic DNA of 24
individuals. Denaturing-high-performance liquid chromatography
(DHPLC) analysis was performed using the WAVE DNA fragment
analysis system (Transgenomic, Cheshire, UK). The temperature
required to successfully to resolve heteroduplex molecules within
each PCR product was determined empirically by injecting the
PCR product at a series of increasing mobile phase temperatures
and constructing a fragment-specific melting curve. A universal
gradient for double-stranded DNA was used to determine the ap-
propriate acetonitrite concentration for heteroduplex identification.
Results were graphically visualized using the D-7000 HSM soft-
ware (Transgenomic).
Direct sequencing of PCR products Putative SNP causing he-
teroduplex formation were confirmed by direct DNA sequencing of
PCR products. PCR products (50–100 ng) were sequenced in both
orientations using the DYEnamic ET terminator cycle sequencing
premix kit from Amersham (Buckinghamshire, UK). Reactions were
fractionated on an ABI3700 automated sequencer (Perkin-Elmer,
Boston, Massachusetts) with standard procedures. Chromato-
graphic traces were analyzed using the SEQUENCHER program
(Gene Codes, Detroit, Michigan), to identify SNP positions.
SNP assay design and SNP genotyping Twenty-nine SNP were
genotyped using Pyrosequencing from Proligo (Biotage, Sweden).
Target sequences were amplified with labelled (biotinylated) and
unlabelled oligonucleotide primers. PCR products were denatured
and sequencing-ready templates isolated by solid-phase streptavi-
din-capture of single-stranded biotinylated products. An internal
DNA sequencing primer was used to generate sequences con-
taining the SNP of interest. In this way, SNP were easily and reliably
validated. All SNP were re-genotyped by another method (Snap-
Shot, ABI) to identify genotyping errors. HLA-Cw6 genotyping has
been performed as described previously (Tazi-Ahnini et al, 1999).
Coefﬁcient of disequilibrium The standardized coefficient of
disequilibrium (D0) between all pairs of SNP was calculated among
founders only with the expectation maximization algorithm of Ex-
coffier and Slatkin (1995). These coefficients were then displayed
graphically with the software GOLD (Abecasis and Cookson,
2000).
Tagging SNP We selected a set of six tagging SNP and tested for
transmission distortion of the haplotypes tagged by these SNP
using the program Transmit (Clayton, 1999; Clayton and Jones,
1999). It was necessary to select six SNP from the 29 available,
since the run-time of Transmit becomes impractical with larger
numbers. The tagging SNP were selected by first estimating ha-
plotypes and their frequencies from the genotype data of founders
only, using the program SNPHAP (http://www-gene.cimr.cam.a-
c.uk/clayton/software/), and then inputting these haplotypes and
corresponding frequencies into the program SNPtagger http://
www.well.ox.ac.uk/  xiayi/haplotype/index.html (Ke and Cardon,
2003) to screen for the best set of six. Transmit program was also
applied to HLA-Cw6 genotyping data.
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